Sen. Grassley Plans Legislation On Independence Of FDA Drug Safety Office
This article was originally published in The Pink Sheet Daily
Executive Summary
Finance Committee chair acknowledges he does not have enough votes for such legislation but says he is starting the "process of educating my colleagues" and "intends to continue that until we get this job done." Grassley's requested GAO report on the Office of Drug Safety will take several months.